New trial of #hydroxychloroquine for #COVID from China. First thoughts: 1- It's a preprint on medRxiv - this means it has yet to be evaluated by the medical community and the information presented may be erroneous (read with a shaker of salt nearby)
2- That said, the research protocol was approved by proper Ethics Cmte at Renmin Hospital in Wuhan, research procedures follow Declaration of Helsinki & registered in Chinese Clinical Trial registry #hydrochloroquine#Covid_19
3- Randomized, double-blinded trial (nice!)
4- Added #hydrochloroquine (200mg 2x/day x 5days) to standard therapy (oxygen, antivirals, antibacterials, immunoglobulins +/- steroids) 5- Patients could not have severe/critical #Covid_19 infection; avg age was ~45y.o., even split M/F.